Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lengfelder

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
International Journal of Cancer|December 17, 1997
p53 mutations in childhood thyroid tumours from Belarus and in thyroid tumours without radiation historyJ Smida, H Zitzelsberger, A M Kellerer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2011
Randomized comparison of pegfilgrastim day 4 versus day 2 for the prevention of chemotherapy-induced leukocytopeniaC Zwick, F Hartmann, S Zeynalova, et al.
Leukemia|August 1, 1996
Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factorC Schoch, D Haase, T Haferlach, et al.
British Journal of Haematology|March 21, 1998
Correlation of cytogenetic, molecular cytogenetic, and clinical findings in 59 patients with ANLL or MDS and abnormalities of the short arm of chromosome 12B Streubel, C Sauerland, G Heil, et al.
Cancer Research|January 19, 1999
Cytogenetic changes in radiation-induced tumors of the thyroidH Zitzelsberger, L Lehmann, L Hieber, et al.
Leukemia|April 1, 1997
Randomized studies with interferon in chronic myelogenous leukemia (CML) and comparative molecular aspects. German CML Study GroupR Hehlmann, A Willer, H Heimpel, et al.
Leukemia|January 26, 2007
A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working groupG Barosi, C Besses, G Birgegard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2007
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)M Pfreundschuh, C Zwick, S Zeynalova, et al.
Blood|June 11, 1999
Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative GroupT Büchner, W Hiddemann, B Wörmann, et al.
Leukemia|September 11, 2009
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCGE Lengfelder, C Haferlach, S Saussele, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|December 17, 1997
p53 mutations in childhood thyroid tumours from Belarus and in thyroid tumours without radiation historyJ Smida, H Zitzelsberger, A M Kellerer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2011
Randomized comparison of pegfilgrastim day 4 versus day 2 for the prevention of chemotherapy-induced leukocytopeniaC Zwick, F Hartmann, S Zeynalova, et al.
Leukemia|August 1, 1996
Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factorC Schoch, D Haase, T Haferlach, et al.
British Journal of Haematology|March 21, 1998
Correlation of cytogenetic, molecular cytogenetic, and clinical findings in 59 patients with ANLL or MDS and abnormalities of the short arm of chromosome 12B Streubel, C Sauerland, G Heil, et al.
Cancer Research|January 19, 1999
Cytogenetic changes in radiation-induced tumors of the thyroidH Zitzelsberger, L Lehmann, L Hieber, et al.
Leukemia|April 1, 1997
Randomized studies with interferon in chronic myelogenous leukemia (CML) and comparative molecular aspects. German CML Study GroupR Hehlmann, A Willer, H Heimpel, et al.
Leukemia|January 26, 2007
A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working groupG Barosi, C Besses, G Birgegard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2007
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)M Pfreundschuh, C Zwick, S Zeynalova, et al.
Blood|June 11, 1999
Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative GroupT Büchner, W Hiddemann, B Wörmann, et al.
Leukemia|September 11, 2009
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCGE Lengfelder, C Haferlach, S Saussele, et al.
Pageof 10